Kirkland Represents AbbVie on $30 Billion Senior Notes Offering

Kirkland & Ellis advised AbbVie Inc. (NYSE: ABBV), a global, research-driven biopharmaceutical company, on its private offering (the "Offering") of senior unsecured notes in a combined aggregate principal amount of $30 billion. The Offering was conducted in connection with AbbVie's previously announced acquisition of Allergan plc.

Read the company press release

The Offering represents the largest corporate bond sale of 2019 and the fourth-largest in history. 

The Kirkland team was led by capital markets partners Sophia Hudson and Maggie Flores and associates Zoey Hitzert, Asher Qazi, Kathryn White and Emma Bolla. The team also included tax partners Sara Zablotney and Adam Kool and associate Simon Kwong.